Givaudan SA
OTC:GVDBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Givaudan SA
OTC:GVDBF
|
CH |
|
Strategic Education Inc
NASDAQ:STRA
|
US |
|
Vaxxinity Inc
OTC:VAXX
|
US |
|
Nozawa Corp
TSE:5237
|
JP |
Wall Street
Price Targets
GVDBF Price Targets Summary
Givaudan SA
According to Wall Street analysts, the average 1-year price target for
GVDBF
is 4 215.6547 USD
with a low forecast of 3 219.964 USD and a high forecast of 5 793.728 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GVDBF's stock price target?
Price Target
4 215.6547
USD
According to Wall Street analysts, the average 1-year price target for
GVDBF
is 4 215.6547 USD
with a low forecast of 3 219.964 USD and a high forecast of 5 793.728 USD.
What is Givaudan SA's Revenue forecast?
Projected CAGR
4%
For the last 14 years the
compound annual growth rate for
Givaudan SA's revenue is
5%.
The projected
CAGR
for the next 3 years is
4%.
What is Givaudan SA's Operating Income forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Givaudan SA's operating income is
8%.
The projected
CAGR
for the next 3 years is
6%.
What is Givaudan SA's Net Income forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Givaudan SA's net income is
11%.
The projected
CAGR
for the next 3 years is
6%.
